Nearly 17,000 people may have died after taking hydroxychloroquine during the first wave of Covid-19, according to a study by French researchers cited by Politico.
The anti-malaria drug has been prescribed to some patients hospitalized with Covid-19 during the first wave of the pandemic, “despite the lack of evidence documenting its clinical benefits,” the researchers said in their paper published in the February issue of Biomedicine & Pharmacotherapy.
Researchers have now estimated that around 16,990 people in six countries – France, Belgium, Italy, Spain, Turkey and the US – may have died as a result.
This figure comes from a study published in the scientific journal Nature in 2021, which reports 11% increase in mortalityrelated to its prescription against Covid-19, due to the potential adverse effects such as heart rhythm disorders and its use instead of other effective treatments.
Mass review of studies after the hydroxychloroquine scandal
Many institutions reported that they were not aware of any contact with Surgisphere
Researchers from the universities of Lyon, France, and Quebec, Canada, used this figure to analyze data on Covid hospitalizations in each of the six countries, exposure to hydroxychloroquine and the increase in relative risk of death associated with the drug.
In fact, they say the figure could be much higher, given that the study only covered six countries from March to July 2020, when the drug is much more widely prescribed.
Hydroxychloroquine gained notoriety in part thanks to the French virologist Didier Raoult, who directed the Méditerranée Infection Foundation hospital, but was later removed amid growing controversy.
Hydroxychloroquine was also touted as something of a “miracle drug” by then-US President Donald Trump, who said: “What have you got to lose? Take it.”
A new blow for Bolsonaro – hydroxychloroquine does not fight the coronavirus
Increased risk of heart and liver problems
2024-01-05 14:32:37
#Hydroxychloroquine #caused #deaths #pandemic
